Radiobiology and cancer

Ferran Guedea i Edo

PRINCIPAL INVESTIGATORS
  • Arturo Navarro Martín
  • Cristina Gutiérrez Miguélez
  • Ferran Ferrer González
  • Juan Luis Ribes Bernal
  • Isabel Linares Galiana
  • Miquel Macià Garau
  • Evelyn Martínez Pérez
  • Maria Aranzazu Eraso Urien
  • Ana Mª Boladeras Inglada
CLINICAL RESEARCHERS
  • Ricard Ramos Izquierdo
  • Milica Stefanovic
  • Maria Laplana Torres
  • Dina Najjari Jamal
  • Míriam Núñez Fernández
  • Andrea Slocker Escarpa
  • Leyre Asiáin Azcárate
  • Maria Cambray Amenós
  • Héctor Pérez Montero
POSTDOCTORAL RESEARCHERS
  • Mònica Pujol Canadell
MANAGEMENT SUPPORT
  • Montserrat Ventura Bujalance
Cancer
Oncobell

Scientific production

27

PAPERS

Average IF: 6,03

17

LED PAPERS

Average IF: 3,94

2 PUBLICATION IN FIRST DECILE

3 PUBLICATIONS IN FIRST QUARTILE

19 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Strnad,V;Polgár,C;Ott,OJ;Hildebrandt,G;Kauer Dorner,D;Knauerhase,H;Major,T et al, Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial, Lancet Oncol., 2023;24(3):doi:10.1016/S1470-2045(23)00018-9
  • Hannoun Levi,JM;Gal,J;Polgar,C;Strnad,V;Loessl,K;Polat,B;Kauer Domer,D et al, Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor, Int. J. Radiat. Oncol. Biol. Phys., 2023;117(5):doi:10.1016/j.ijrobp.2023.06.075
  • Pons Riverola,A;Morillas,H;Berdejo,J;Pernas,S;Pomares,H;Asiain,L;Garay,A et al, Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments., Cancers, 2023;15(24):doi:10.3390/cancers15245885
  • Garcia Exposito,N;Ramos,R;Navarro Perez,V;Molina,K;Arnaiz,MD;Padrones,S;Ruffinelli,JC et al, Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results, Cancers, 2023;15(4):doi:10.3390/cancers15041195
  • Garcia Tejedor,A;Ortega Exposito,C;Salinas,S;Luzardo Gonzalez,A;Falo,C;Martinez Perez,E;Perez Montero,H et al, Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial), Front. Oncol., 2023;131184021-1184021, doi:10.3389/fonc.2023.1184021

Research highlights

PROJECTS

2 Granted competitive projects
2 Ongoing competitive projects

2 Ongoing clinical trials
3 Ongoing non competitive projects

PUBLISHED WORKS

2 Clinical guidelines

NETWORKS

AGAUR SGR GRC

Selected projects

  • MCI22002. RADIOTERAPIA DE PRECISIÓN: FIRMA MOLECULAR PREDICTIVA PARA RADIOSENSIBILIDAD EN CÁNCER DE MAMA. Ministerio de Ciencia e Innovación. Budget: 110.013€. 2022-2025. PI: GUEDEA EDO, FERRAN.
  • AGA23009. Programa Investigo de contractació de persones joves demandants d’ocupació en la realització d’iniciatives de recerca i innovació (INVESTIGO 2023). AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. Budget: 66217,84. 2023-2025. PI: GUEDEA EDO, FERRAN.
  • 2023-018-1. A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator’s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-based Chemotherapy-ineligible Elderly Patients with Locally Advanced Head & Neck Squamous Cell Carcinoma. NANOBIOTIX. Budget: 42.534€. 2022- . PI: Linares Galiana, Isabel.
  • 16PNJ017. Detection of systemic immune response in peripheral blood proveided by high radiation doses delivered over lung in stereostatic conditions. 2016- . PI: Navarro Martín, Arturo.
  • 16ACL044. ESTUDIO DE FASE 3 ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO DE JNJ-56021927 EN SUJETOS CON CÁNCER DE PRÓSTATA LOCALIZADO O LOCALMENTE AVANZADO Y DE ALTO RIESGO QUE ESTÁN RECIBIENDO TRATAMIENTO CON RADIOTERAPIA PRIMARIA. Janssen-Cilag, S.A. 2016- . PI: Boladeras Inglada, Ana Mª.